Organoids for Metabolic Disease Modeling

Area of Science:

• Biochemistry
• Genetics
• Developmental Biology

Background:

• Inherited metabolic diseases (IMDs) are rare genetic disorders affecting metabolic pathways, causing severe health issues.
• Current disease models (animal, 2D cell cultures) have limitations in fully representing IMD complexity.
• Organoids, as 3D in vitro models, can recapitulate key metabolic functions lost in simpler models.

Purpose of the Study:

• To highlight the utility of organoids in modeling inherited metabolic diseases.
• To propose a functional-centric approach for selecting disease models.
• To emphasize the potential of organoid models for advancing therapeutic strategies and personalized medicine.

Main Methods:

• Review of existing literature on IMD models.
• Analysis of organoid capabilities in mimicking metabolic functions.
• Case examples of organoids modeling specific IMDs (e.g., methylmalonic acidemia, Wilson's disease, cystic fibrosis).

Main Results:

• Organoids effectively model disease-specific metabolic defects.
• Organoids bridge the gap between simple 2D models and complex organ systems.
• Functional relevance is key for effective disease modeling, surpassing strict organ origin.

Conclusions:

• Organoid models provide a powerful platform for studying IMDs.
• A function-focused approach optimizes model selection for IMD research.
• This strategy facilitates the development of novel therapeutics and personalized medicine for IMDs.